#dcgiapproval
India Approves QDENGA, First Dengue Vaccine for Ages 4-60
India approves QDENGA for dengue prevention in people aged 4–60, making it the country’s first authorised dengue vaccine. The two-dose shot targets all four serotypes and is given three months apart, while rollout, pricing and access details are still awaited. QDENGA Approval Marks a First for India India’s drug regulator has approved Takeda’s QDENGA for preventing dengue in people aged four to 60 years, making it the first dengue
India Approves QDENGA, First Dengue Vaccine for Ages 4-60
India approves QDENGA for dengue prevention in people aged 4–60, making it the country’s first authorised dengue vaccine. The two-dose shot targets all four serotypes and is given three months apart, while rollout, pricing and access details are still awaited. QDENGA Approval Marks a First for India India’s drug regulator has approved Takeda’s QDENGA for preventing dengue in people aged four to 60 years, making it the first dengue









